Drug-Induced Hepatotoxicity
The DOI matches its Crossref record; 182 of the 182 references it cites were found in a registry or an index.
Abstract
Drug-induced hepatic injury accounts for more than 50 percent of cases of acute liver failure in the United States. More than 75 percent of idiosyncratic drug reactions result in liver transplantation or death. This review discusses the pathogenesis of drug-induced liver injury, common adverse drug reactions involving the liver, and the drug-approval process. Monitoring for and recognition of drug-induced hepatotoxicity may prevent some cases of acute hepatic failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is known that many variables, such as genetic variability, race, sex, age, metabolic capacity, drug-drug interactions, and preexisting diseases, contribute to individual susceptibility and toxicity of idiosyncratic drugs (Lee, 2003).”
From Mitochondrial Dysfunction Induced by Sertraline, an Antidepressant Agent (2012) · cites this paper as Lee, 2003
In the citing paper
“Under these limited conditions, two-dimensional (2D) monolayered cells exhibit altered biological features, including morphology, function, hepatic polarity, and genotype expression (Lasser et al., 2002;Lee, 2003;Ma et al., 2023).”
From Fast formation and maturation enhancement of human liver organoids using a liver-organoid-on-a-chip (2024) · cites this paper as Lee, 2003
Citations
Cites
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Self-citationEarly indicators of prognosis in fulminant hepatic failure
O'Grady, J. G., Alexander, G. J. M., Hayllar, K. M., & Williams, R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90081-4 · Cited by 2,085
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. IV. PROTECTIVE ROLE OF GLUTATHIONE
Mitchell, J. R., Jollow, D. J., Potter, W. Z., Gillette, J. R., & Brodie, B. B. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29666-5 · Cited by 1,737
Role of Quinones in Toxicology
Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., & Monks, T. J. (2000) · Chemical Research in Toxicology · doi:10.1021/tx9902082 · Cited by 1,703
Common and Uncommon Cytochrome P450 Reactions Related to Metabolism and Chemical Toxicity
Guengerich, F. P. (2001) · Chemical Research in Toxicology · doi:10.1021/tx0002583 · Cited by 1,655
Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481
Jaeschke, H. (2002) · Toxicological Sciences · doi:10.1093/toxsci/65.2.166 · Cited by 1,304
McDonald, G. B., Hinds, M. S., Fisher, L. D., Schoch, H. G., Wolford, J. L., Banaji, M., Hardin, B. J., Shulman, H. M., & Clift, R. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-4-199302150-00003 · Cited by 1,202
Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose
Smilkstein, M. J., Knapp, G. L., Kulig, K. W., & Rumack, B. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812153192401 · Cited by 1,102
Research works printed but not linked: 9
- Yun CH, 1993, Drug Metab Dispos, 21, 403
- Chitturi S, 2001, Semin Gastrointest Dis, 12, 113
- Wang K, 1999, Zhonghua Yi Xue Za Zhi (Taipei), 62, 369
- George J, 1995, Hepatology, 21, 120
- Meadows M, 2001, FDA Consum, 35, 8
- Piliero PJ, 2001, AIDS Read, 11, 379
- 10.1111/j.1572-0241.1999.01091.x · doi:10.1111/j.1572-0241.1999.01091.x · Paper page
- Fernandes NF, 2000, Am J Gastroenterol, 95, 532, 10.1111/j.1572-0241.2000.t01-1-01780.x · doi:10.1111/j.1572-0241.2000.t01-1-01780.x · Paper page
- Graham DJ, 2002, Hepatology, 36, 168A
Cited by
Items 301–400 of 1,000
Renal toxic ingredients and their toxicology from traditional Chinese medicine
Xu, X.-L., Yang, L.-J., & Jiang, J. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2016.1132306 · Cited by 68
Tutty, M. A., Movia, D., & Prina‐Mello, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01147-0 · Cited by 75
Ferrajolo, C., Capuano, A., Verhamme, K. M. C., Schuemie, M., Rossi, F., Stricker, B. H., & Sturkenboom, M. C. J. M. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03754.x · Cited by 68
Opioid and non-opioid analgesics
Schug, S. A., Garrett, W. R., & Gillespie, G. (2003) · Best practice & research. Clinical anaesthesiology · doi:10.1053/bean.2003.0267 · Cited by 75
(2015) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2015.00007 · Cited by 55
Drug safety testing paradigm, current progress and future challenges: an overview
Ahuja, V., & Sharma, S. C. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2935 · Cited by 73
Protective Effect of Quercetin on Chloroquine-Induced Oxidative Stress and Hepatotoxicity in Mice
Mishra, S. K., Singh, P. K., & Rath, S. K. (2013) · Malaria Research and Treatment · doi:10.1155/2013/141734 · Cited by 71
Evolution of systemic therapy of advanced hepatocellular carcinoma
Yau, T. C. C., Chan, P., Epstein, R. J., & Poon, R. T. P. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.6437 · Cited by 66
Moore, N. D. (2007) · Clinical Drug Investigation · doi:10.2165/00044011-200727030-00002 · Cited by 64
Teo, Y. L., Ho, H. K., & Chan, A. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.983075 · Cited by 64
Severe Hepatotoxicity Associated With Bromfenac Sodium
Moses, P. L., Schroeder, B., Alkhatib, O., Ferrentino, N., Suppan, T., & Lidofsky, S. D. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00149-5 · Cited by 64
Xiang, Y., Ma, L., Wu, W., Liu, W., Li, Y., Zhu, X., Wang, Q., Ma, J., Cao, M., Wang, Q., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085905 · Cited by 64
Burbank, M., Burban, A., Sharanek, A., Weaver, R. J., Guguen‐Guillouzo, C., & Guillouzo, A. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.071373 · Cited by 69
NLRP3 Inflammasome and IL-33: Novel Players in Sterile Liver Inflammation
Neumann, K., Schiller, B., & Tiegs, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092732 · Cited by 69
Genomic indicators in the blood predict drug-induced liver injury
Huang, J., Shi, W., Zhang, J., Chou, J., Paules, R. S., Gerrish, K., Li, J., Luo, J., Wolfinger, R. D., Bao, W., et al. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.33 · Cited by 63
Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes
Oorts, M., Baze, A., Bachellier, P., Heyd, B., Zacharias, T., Annaert, P., & Richert, L. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.03.008 · Cited by 66
Ibuprofen: Pharmacology, Therapeutics and Side Effects
Rainsford, K. D. (2012) · Springer eBooks · doi:10.1007/978-3-0348-0496-7 · Cited by 80
Akinmoladun, A. C., Oladejo, C. O., Josiah, S. S., Famusiwa, C. D., Ojo, O. B., & Olaleye, M. T. (2018) · Pathophysiology · doi:10.1016/j.pathophys.2018.07.002 · Cited by 63
Wu, L., Ding, Q., Wang, X., Li, P., Fan, N., Zhou, Y., Tong, L., Zhang, W., Zhang, W., & Tang, B. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b04411 · Cited by 64
CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity
Neuman, M. G., Shear, N. H., Jacobson-Brown, P., Katz, G. G., Neilson, H. K., Malkiewicz, I. M., Cameron, R., & Abbott, F. S. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(01)00217-x · Cited by 63
Acute and fulminant hepatitis induced by flutamide: Case series report and review of the literature
Javier, B., Magdalena, B., Roberto, S., Ricardo, L., Rodrigo, Z., Jaime, P., Erwin, B., & Luis, C. (2011) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31595-9 · Cited by 62
Risk of oral antifungal agent‐induced liver injury in T aiwanese
Kao, W., Su, C., Huang, Y., Chou, Y., Chen, Y., Chung, W., Hou, M., Lin, H., Lee, F., & Wu, J. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12178 · Cited by 66
Rohilla, R., Garg, T., Goyal, A. K., & Rath, G. (2014) · Drug Delivery · doi:10.3109/10717544.2014.945018 · Cited by 67
Novaes, R. D., dos Santos, E. C., Cupertino, M. C., Bastos, D. S. S., de Oliveira, J. M., de Carvalho, T. V., Machado‐Neves, M., de Oliveira, L. L., & Talvani, A. (2015) · Parasitology Research · doi:10.1007/s00436-015-4488-x · Cited by 62
Noor, F., Niklas, J., Müller‐Vieira, U., & Heinzle, E. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.03.011 · Cited by 67
N -acetylcysteine amide, a promising antidote for acetaminophen toxicity
Khayyat, A. N., Tobwala, S., Hart, M. L., & Ercal, N. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.11.008 · Cited by 71
Drug-induced liver injury in Oncology
Ricart, A. D. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx158 · Cited by 64
Primary hepatocytes as a model to analyze species-specific toxicity and drug metabolism
Tuschl, G., Lauer, B., & Mueller, S. O. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.7.855 · Cited by 62
Hassen, A., Belachew, T., Yami, A., & Ayen, W. Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064622 · Cited by 61
Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase
Bergman, E., Forsell, P., Åberg, A. T., Persson, E. M., Hedeland, M., Bondesson, U., Knutson, L., & Lennernäs, H. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.015 · Cited by 65
Endoplasmic Reticulum Stress in Drug- and Environmental Toxicant-Induced Liver Toxicity
Chen, S., Melchior, W. B., & Guo, L. (2014) · Journal of Environmental Science and Health Part C · doi:10.1080/10590501.2014.881648 · Cited by 63
Hepatitis associated with terbinafine therapy: three case reports and a review of the literature
Gupta, A. K., Rosso, D., Lynde, Brown, & Shear (1998) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.1998.00321.x · Cited by 61
Atienzar, F. A., Blomme, E. A., Chen, M., Hewitt, P., Kenna, J. G., Labbe, G., Moulin, F., Pognan, F., Roth, A. B., Suter-Dick, L., et al. (2016) · BioMed Research International · doi:10.1155/2016/9737920 · Cited by 59
Watkins, P. B., Dubé, L. M., Walton-Bowen, K. L., CAMERON, C. M., & Kasten, L. E. (2007) · Drug Safety · doi:10.2165/00002018-200730090-00006 · Cited by 62
Nonsteroidal Anti-Inflammatory Drug–Induced Hepatoxicity
Unzueta, A., & Vargas, H. E. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.07.009 · Cited by 66
Zhang, M., Chen, M., & Tong, W. (2012) · Chemical Research in Toxicology · doi:10.1021/tx200320e · Cited by 58
Sawada, K., Hayashi, H., Nakajima, S., Hasebe, T., Fujiya, M., & Okumura, T. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14889 · Cited by 54
The potential of cytokines as safety biomarkers for drug-induced liver injury
Laverty, H., Antoine, D. J., Benson, C. A., Chaponda, M., Williams, D. P., & Park, B. K. (2010) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0862-x · Cited by 64
Polymorphisms of CYP2D6 Gene and Gefitinib-Induced Hepatotoxicity
Takimoto, T., Kijima, T., Otani, Y., Nonen, S., Namba, Y., Mori, M., Yokota, S., Minami, S., Komuta, K., Uchida, J., et al. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.03.003 · Cited by 63
Adverse Reactions to Antituberculosis Drugs in Iranian Tuberculosis Patients
Farazi, A., Sofian, M., Jabbariasl, M., & Keshavarz, S. (2014) · Tuberculosis Research and Treatment · doi:10.1155/2014/412893 · Cited by 59
Holt, M. R., Yin, H., & Ju, C. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.01.020 · Cited by 60
Risperidone-induced cholestatic hepatitis
Krebs, S., Dormann, H., Muth‐Selbach, U., Hahn, E. G., Brune, K., & Schneider, H. T. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200101000-00013 · Cited by 59
PROXIMAL: a method for Prediction of Xenobiotic Metabolism
Yousofshahi, M., Manteiga, S., Wu, C., Lee, K., & Hassoun, S. (2015) · BMC Systems Biology · doi:10.1186/s12918-015-0241-4 · Cited by 58
Cosgrove, B. D., Alexopoulos, L. G., Hang, T.-C., Hendriks, B. S., Sorger, P. K., Griffith, L. G., & Lauffenburger, D. A. (2010) · Molecular BioSystems · doi:10.1039/b926287c · Cited by 63
Re, V. L., Haynes, K., Goldberg, D. S., Forde, K. A., Carbonari, D. M., Leidl, K. B. F., Hennessy, S., Reddy, K. R., Pawloski, P. A., Daniel, G. W., et al. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3470 · Cited by 58
Decloedt, E. H., McIlleron, H., Smith, P. J., Merry, C., Orrell, C., & Maartens, G. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01598-10 · Cited by 58
Aleo, M. D., Shah, F., Allen, S. W., Barton, H. A., Costales, C., Lazzaro, S., Leung, L. Y., Nilson, A. L., Obach, R. S., Rodrigues, A. D., et al. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00262 · Cited by 58
Aguesse-Germon, S., Liu, S.-H., Chevallier, M., Pichoud, C., Jamard, C., Borel, C., Chu, C. K., TREPO, C. G., Cheng, Y., & Zoulim, F. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.369 · Cited by 58
El‐Magd, N. F. A., & Eraky, S. M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117331 · Cited by 57
Sagor, A. T., Chowdhury, M. R. H., Tabassum, N., Hossain, H., Rahman, M., & Alam, M. A. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0636-1 · Cited by 58
Pang, C., Sheng, Y., Jiang, P., Wei, H., & Ji, L. (2015) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1400346 · Cited by 58
Hadi, M., Westra, I. M., Starokozhko, V., Dragovic, S., Merema, M. T., & Groothuis, G. M. M. (2013) · Chemical Research in Toxicology · doi:10.1021/tx300519p · Cited by 55
Microfluidic-Based Multi-Organ Platforms for Drug Discovery
Rezaei Kolahchi, A., Khadem Mohtaram, N., Pezeshgi Modarres, H., Mohammadi, M., Geraili, A., Jafari, P., Akbari, M., & Sanati-Nezhad, A. (2016) · Micromachines · doi:10.3390/mi7090162 · Cited by 53
Prediction models for drug-induced hepatotoxicity by using weighted molecular fingerprints
Kim, E., & Nam, H. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1638-4 · Cited by 58
Khan, S. A., Mandal, R. K., Elasbali, A. M., Dar, S. A., Jawed, A., Wahid, M., Mahto, H., Lohani, M., Mishra, B. N., Akhter, N., et al. (2018) · Bioscience Reports · doi:10.1042/bsr20180845 · Cited by 61
Almatroodi, S. A., Anwar, S., Almatroudi, A., Khan, A. A., Alrumaihi, F., Alsahli, M. A., & Rahmani, A. H. (2020) · Applied Sciences · doi:10.3390/app10186200 · Cited by 58
Ukelis, U., Kramer, P.-J., Olejniczak, K., & Mueller, S. O. (2008) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2008.02.002 · Cited by 57
Acarbose-induced hepatic injury
Fujimoto, Y., Ohhira, M., Miyokawa, N., Kitamori, S., & Kohgo, Y. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78337-9 · Cited by 57
Potential Effects of Coronaviruses on the Liver: An Update
Wang, X., Lei, J., Li, Z., & Yan, L. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.651658 · Cited by 57
Luis, P. B., Ruiter, J. P. N., Aires, C. C. P., Soveral, G., de Almeida, I. T., Durán, M., Wanders, R. J. A., & Silva, M. F. B. (2007) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2007.06.007 · Cited by 56
Venkatesh, M., Wang, H., Cayer, J., Leroux, M., Salvail, D., Das, B. C., Wrobel, J. E., & Mani, S. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.071787 · Cited by 56
Stieger, B., & Geier, A. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.557067 · Cited by 59
Adverse outcome pathway development from protein alkylation to liver fibrosis
Horvat, T., Landesmann, B., Lostia, A., Vinken, M., Munn, S., & Whelan, M. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1814-8 · Cited by 53
Mora, J. R., Marrero‐Ponce, Y., García‐Jacas, C. R., & Causado, A. S. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00030 · Cited by 61
Ishikawa, T., Takahashi, T., Taniguchi, T., & Hosoya, T. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1918102 · Cited by 55
Guo, Y.-X., Xu, X. F., Zhang, Q. Z., Li, C., Deng, Y., Jiang, P., He, L. Y., & Peng, W. (2015) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2015.1033074 · Cited by 55
EFFECTS OF FENOFIBRATE AND XUEZHIKANG ON HIGH‐FAT DIET‐INDUCED NON‐ALCOHOLIC FATTY LIVER DISEASE
Hong, X. Z., Li, L. D., & Wu, L. M. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04547.x · Cited by 54
Age-Related Changes in the Hepatic Pharmacology and Toxicology of Paracetamol
Mitchell, S. J., Kane, A. E., & Hilmer, S. N. (2011) · Current Gerontology and Geriatrics Research · doi:10.1155/2011/624156 · Cited by 56
Liver Chemistry and Function Tests
Pratt, D. S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00073-1 · Cited by 64
Alessandrino, F., Tirumani, S. H., Krajewski, K. M., Shinagare, A. B., Jagannathan, J. P., Ramaiya, N. H., & Salvo, D. N. D. (2017) · Clinical Radiology · doi:10.1016/j.crad.2017.04.003 · Cited by 60
Prediction of Drug-Induced Liver Toxicity Using SVM and Optimal Descriptor Sets
Jaganathan, K., Tayara, H., & Chong, K. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158073 · Cited by 59
Yokoi, T. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00663-0_14 · Cited by 55
Wu, Z., Wen, T., Tan, Y., Liu, Y., Ren, F., & Wu, H. (2007) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7835.2007.00020.x · Cited by 56
Kumar, B. S., Chung, B. C., Lee, Y. J., Yi, H. J., Lee, B., & Jung, B. H. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.09.031 · Cited by 55
Randle, L. E., Goldring, C. E., Benson, C. A., Metcalfe, P., Kitteringham, N. R., Park, B. K., & Williams, D. P. (2007) · Toxicology · doi:10.1016/j.tox.2007.10.011 · Cited by 56
Acute Drug-Induced Hepatitis Caused by Albendazole
Choi, G. Y., Yang, H. W., Cho, S. H., Kang, D. W., Go, H., Lee, W. C., Lee, Y. J., Jung, S. H., Kim, A. N., & Cha, S. W. (2008) · Journal of Korean Medical Science · doi:10.3346/jkms.2008.23.5.903 · Cited by 54
Self-citationHepatoprotective Activity of Rauwolfia serpentina Rhizome in Paracetamol Intoxicated Rats
Gupta, A. K., Chitme, H. R., Dass, S. K., & Misra, N. (2005) · Journal of Pharmacology and Toxicology · doi:10.3923/jpt.2006.82.88 · Cited by 61
Cai, Q.-Y., Wei, J., Zhao, W., Shi, S., Zhang, Y., Wei, R., Zhang, Y., Li, W., & Wang, Q. (2014) · Molecules · doi:10.3390/molecules191221168 · Cited by 58
Amacher, D. E., Schomaker, S., & Aubrecht, J. (2013) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-013-0049-0 · Cited by 56
Field Evaluation of a Prototype Paper-Based Point-of-Care Fingerstick Transaminase Test
Pollock, N. R., McGray, S., Colby, D. J., Noubary, F., Nguyen, H., Nguyen, T. A., Khormaee, S., Jain, S., Hawkins, K. R., Kumar, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075616 · Cited by 54
The hepatic safety profile of duloxetine: a review
McIntyre, R. S., Panjwani, Z. D., Nguyen, H. T., Woldeyohannes, H. O., Alsuwaidan, M., Soczynska, J. K., Lourenco, M. T., Konarski, J. Z., & Kennedy, S. H. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.3.281 · Cited by 54
“Autoimmune(-Like)” drug and herb induced liver injury: new insights into molecular pathogenesis
Sebode, M., Schulz, L., & Lohse, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091954 · Cited by 47
Castro, A. T. E., Mendes, M., Freitas, S., & Roxo, P. C. (2015) · Revista Portuguesa de Pneumologia · doi:10.1016/j.rppnen.2014.08.004 · Cited by 53
Involvement of the Immune System in Idiosyncratic Drug Reactions
Zhang, X., Liu, F., Chen, X., Zhu, X., & Uetrecht, J. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-10-rv-085 · Cited by 63
Elefsiniotis, I. S., Liatsos, G. D., Stamelakis, D., & Moulakakis, A. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.9968 · Cited by 53
Genome-wide association and replication study of anti-tuberculosis drugs-induced liver toxicity
Petros, Z., Lee, M.-T. M., Takahashi, A., Zhang, Y., Yimer, G., Habtewold, A., Amogne, W., Aderaye, G., Schuppe-Koistinen, I., Mushiroda, T., et al. (2016) · BMC Genomics · doi:10.1186/s12864-016-3078-3 · Cited by 50
Zhang, T., Ikejima, T., Li, L., Wu, R., Yuan, X., Zhao, J., Wang, Y., & Peng, S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00753 · Cited by 54
Phenprocoumon-induced liver disease ranges from mild acute hepatitis to (sub-) acute liver failure
Schimanski, C. C., Burg, J., Möhler, M., Höhler, T., Kanzler, S., Otto, G., Galle, P. R., & Lohse, A. W. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.03.010 · Cited by 53
Hepatic injury, liver monitoring and the beta-interferons for multiple sclerosis
Tremlett, H. L., & Oger, J. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0619-5 · Cited by 54
Accumulation of macrophages in primary sclerosing cholangitis
Cameron, R., Blendis, L. M., & Neuman, M. G. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(01)00215-6 · Cited by 54
Alcohol-acetaminophen syndrome: Even moderate social drinkers are at risk
Draganov, P., Durrence, H., Cox, C., & Reuben, A. (2000) · Postgraduate Medicine · doi:10.3810/pgm.2000.01.831 · Cited by 52
Liu, Q., Yuan, J., Jiang, R., He, L., Yang, X., Yuan, L., & Cheng, D. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c04894 · Cited by 52
Andersson, U., Lindberg, J., Wang, S., Balasubramanian, R., Marcusson-Ståhl, M., Hannula, M., Zeng, C., Juhasz, P. J., Kolmert, J., Bäckström, J., et al. (2009) · Biomarkers · doi:10.3109/13547500903261354 · Cited by 50
Histopathologic Manifestations of Drug-induced Hepatotoxicity
Zhang, X., Ouyang, J., & Thung, S. N. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.07.004 · Cited by 45
High-content screening of drug-induced mitochondrial impairment in hepatic cells: effects of statins
Tolosa, L., Carmona, A. L., Castell, J. V., Gómez‐Lechón, M. J., & Donato, M. T. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1334-3 · Cited by 55
Greaves, P. (2012) · Elsevier eBooks · doi:10.1016/b978-0-444-53856-7.00009-9 · Cited by 61
Li, S., Wang, N., Hong, M., Tan, H., Pan, G., & Feng, Y. (2018) · Molecules · doi:10.3390/molecules23020352 · Cited by 52
Clarke, J. I., Dear, J. W., & Antoine, D. J. (2016) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1160057 · Cited by 46
Tuberculosis and Nontuberculous Mycobacterial Infections in Older Adults
Schluger, N. W. (2007) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2007.07.004 · Cited by 51
Kegel, V., Pfeiffer, E., Burkhardt, B., Liu, J. L., Zeilinger, K., Nüssler, A. K., Seehofer, D., & Damm, G. (2015) · Mediators of Inflammation · doi:10.1155/2015/640631 · Cited by 47
Metadata
- Authors
- Lee, W. M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Lee, William M.
- ORCID
- Lee, William M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-07-31
- Volume
- 349
- Issue
- 5
- Pages
- 474-485
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3021092633
- Cited by
- 1,594
- References
- 180
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 33 · 2023: 41 · 2022: 44 · 2021: 44 · 2020: 53 · 2019: 69 · 2018: 69 · 2017: 75 · 2016: 84 · 2015: 74 · 2014: 95 · 2013: 88 · 2012: 88
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- drug-induced liver injury, acute liver failure, idiosyncratic drug reactions, adverse drug reactions, drug approval, hepatotoxicity monitoring, liver transplantation
- MeSH terms
- Troglitazone, Anti-Inflammatory Agents, Non-Steroidal, Benzophenones, Bromobenzenes, Chromans, Pharmaceutical Preparations, Humans, Hypoglycemic Agents, Liver, Liver Cirrhosis, Liver Diseases, Liver Function Tests, Pharmacology, Thiazoles, Drug Approval, Thiazolidinediones, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.